The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FIRE-4 (AIO KRK-0114): Randomized study evaluating the efficacy of cetuximab re-challenge in patients with metastatic RAS wild-type colorectal cancer responding to first-line treatment with FOLFIRI plus cetuximab.
 
Lena Weiss
Honoraria - Roche; SERVIER
Travel, Accommodations, Expenses - Amgen
 
Volker Heinemann
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck; MSD; Novartis; Oncosil; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; AstraZeneca; GlaxoSmithKline; Halozyme; Janssen; Merck; MSD; Nordic Bioscience; Oncosil; Pierre Fabre; Roche; Servier/Pfizer; TERUMO
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst); Servier (Inst)
Expert Testimony - Oncosil; Servier
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Merck; MSD; Nordic Bioscience
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Florian Kaiser
Consulting or Advisory Role - Abbvie; Astellas Pharma; Elsevier; Gilead Sciences; GlaxoSmithKline; Janssen; MSD; Novartis; Pierre Fabre; Sanofi; Sanofi; Servier
 
Martin Fuchs
No Relationships to Disclose
 
Gerald Prager
Consulting or Advisory Role - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Bayer; BMSi; Merck Serono; MSD; Pierre Fabre; Roche/Genentech; SERVIER; Taiho Oncology; Takeda
 
Kathrin Heinrich
Honoraria - Amgen; Bristol-Myers Squibb; Merck KGaA; MSD; Roche Pharma AG; SERVIER; Streamedup!; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Amgen; Janssen; Merck KGaA; MSD (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Merck KGaA; SERVIER
(OPTIONAL) Uncompensated Relationships - DKG Krebsgesellschaft
 
Andreas Dickhut
No Relationships to Disclose
 
Ralf Hofheinz
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Falk Foundation; GlaxoSmithKline; LEO Pharma; Lilly; Medac; Merck Serono; MSD; Nordic Bioscience; Onkowissen; Pierre Fabre; Roche; Sanofi; Servier; SYNLAB; Takeda; WALA
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; GlaxoSmithKline; LEO Pharma; Lilly; Merck Serono; MSD; Nordic Group; Roche; Sanofi; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - German Cancer Aid (Inst)
 
Thomas Decker
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Novartis
 
Stefan Angermeier
No Relationships to Disclose
 
Tom Ganten
No Relationships to Disclose
 
Christof Burkart
Consulting or Advisory Role - MSD
 
Matthias Sandmann
No Relationships to Disclose
 
Leopold Öhler
No Relationships to Disclose
 
Dominik Modest
Honoraria - 21up; Amgen; AstraZeneca; Bicara Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Cor2Ed; GlaxoSmithKline; IKF Klinische Krebsforschung; Lilly; Merck; Merck Serono; Onkowissen; Pierre Fabre; Regeneron; Rottapharm Biotech; Seagen; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Cor2Ed; GlaxoSmithKline; Incyte; Lilly; Merck Serono; Onkowissen; Pierre Fabre; Regeneron; SERVIER; Takeda
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Dora Niedersuess -Beke
Consulting or Advisory Role - BMS GmbH & Co. KG; MSD Oncology
Speakers' Bureau - Astellas Pharma; BMS GmbH & Co. KG; Ipsen; MSD Oncology
Research Funding - Astellas Pharma
 
Thomas Kubin
No Relationships to Disclose
 
Swantje Held
No Relationships to Disclose
 
Sebastian Stintzing
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb GmbH; Daiichi Sankyo Europe GmbH; Merck KGaA; MSD; Nordic Bioscience; Pfizer; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; CV6 Therapeutics; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Isofol Medical; Merck KGaA; MSD; Nordic Bioscience; Pierre Fabre; Roche; Seagen; SERVIER; TERUMO
Research Funding - Amgen (Inst); Merck Serono (Inst); MSD (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - Servier (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda